The U.S. FDA approves the use of plasma from survivors of the novel coronavirus as a treatment method, New Zealand will extend the local three-level lockdown measures by one more week

In Daily Market Review, English
25 8 月, 2020

The U.S. FDA approves the use of plasma from survivors of the novel coronavirus as a treatment method
The U.S. Food and Drug Administration (FDA) announced on Sunday (23rd) that it has approved the use of plasma from patients who have recovered from the novel coronavirus as a treatment for the disease, and issued an emergency use permit. The FDA stated in a statement that plasma therapy may be effective in treating the new coronavirus, and its known and potential benefits outweigh the risks, and pointed out that more than 70,000 patients with the new coronavirus have used plasma therapy. However, the effectiveness of this therapy is still questioned by some foreign experts, and even warned that plasma therapy may have side effects “serum sickness”, which may lead to organ failure in severe cases.

New Zealand will extend the local three-level lockdown measures by one more week
New Zealand Prime Minister Ardern announced on Monday (24th) that the local three-level lockdown measures will be extended for at least one week, including forcing people to wear masks on public transportation. Affected by the epidemic lockdown measures, New Zealand’s retail sales fell 14.2% year-on-year in the second quarter of this year, ending the quarterly upward trend and marking the largest decline in 25 years. The market estimates that under the blockade restrictions, it will cause about 440 million New Zealand dollars in economic losses every week, equivalent to 0.15% of the annual GDP. If the blockade measures are not lifted in the short term, it will have a major impact on the local economy.

—————————————————————

Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/

場外式黃金/白銀交易的風險:
場外式黃金/白銀交易由 Max Online 提供。場外式黃金/白銀交易涉及高度風險,未必適合所有投資者。高度的槓桿可為閣下帶來負面或正面的影響。場外式黃金/白銀並非受證券及期貨事務監察委員會(「證監會」)監管,因此買賣場外式黃金/白銀將不會受到證監會所頒布的規則或規例所約束,包括(但不限於)客戶款項規則。閣下在決定買賣場外式黃金/白銀之前應審慎考慮自己的投資目標、交易經驗以及風險接受程度。可能出現的情況包括蒙受部分或全部初始投資額的損失,或在極端情況下(例如相關市場跳空)產生更多的損失。因此,閣下不應將無法承受損失的資金用於投資。投資應知悉買賣場外式黃金/白銀有關的一切風險,如有需要,請向獨立財務顧問尋求意見。